Patent Assignment
Reel/Frame 050890/0760
Merger
Recorded: 2019-10-25
Pages: 4
Assignor
INHIBRX, LP
Executed: 2018-04-30
Assignee
INHIBRX, INC.
11099 NORTH TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(3)
CD47 Antibodies and Methods of Use Thereof
CD47 Antibodies and Methods of Use Thereof
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
14/841,619 →
Publication:
US 2016/0251435
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 10, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 030766/0522 →
Assignment of Assignor's Interest
Sep 15, 2015
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 036571/0681 →
Assignment of Assignor's Interest
May 11, 2016
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX, LLC
Reel/Frame 038554/0506 →
Change of Name
May 11, 2016
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 038685/0028 →
Change of Name
Aug 25, 2016
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 039738/0543 →
Change of Name
Oct 25, 2019
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 050832/0610 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →